Three separate Associated Press stories on Thursday, December 28, reported the networks' actions and elicited from Marlin Fitzwater, the White House spokesman, the opinion that the
Drixoral ad was in bad taste.
Over the-counter antihistamines such as Benadryl and Tavist may stop itching and sneezing caused by seasonal allergies, and nasal decongestants such as Actifed,
Drixoral, and Sudafed may relieve a stuffy nose.
Therefore, numerous combinations of antihistamines with decongestants are available: Actifed,(R)* A.R.M.,(R)* Chlor-Trimeton D,(R)* Contac,(R)* CoPyronil 2,(R)* Deconamine,(R)* Demazin,(R)* Dimetapp,(R)*
Drixoral,(R)* Isoclor,(R)* Nolamine,(R) Novafed A,(R)* Ornade,(R) Sudafed Plus,(R) Tavist D,(R) Triaminic,(R)* Trinalin,(R) just to name a few.
Schering-Plough HealthCare Products reported increased sales of
Drixoral, an antihistamine and decongestant.
Other products in this division include such medications as Afrin nasal spray, ChlorTrimeton allergy tablets, Coricidin and
Drixoral cold remedies, Gyne-Lotrimin for vaginal yeast infections, foot care items sold under the Dr.
Other entries included Schering Laboratories'
Drixoral Plus anthistamine/nasal decongestant; A.H.
On a brand basis heavily consuming females 55 to 64 are most likely to purchase private label products, followed by Benadryl, Sudafed, Tylenol Sinus and
Drixoral. Private label's strength here may be due, in part, to the fact that older consumers are often less loyal to national brands than are young ones.
Robins, in tablet and liquid form, take aim at the gains made by their Rx-to-OTC predecessors, Actifed and
Drixoral.
Drixoral, in new liquid form, heightens the battle.
They include Sudafed tablets, Dimetapp Extentabs, Dibromm extended-release tablets,
Drixoral 12-hour cold tablets and Hy-Vee's own Suphedrine brand tablets.
The HBA buyer for a Midwest chain credits recently de-Rxed drugs, such as Burroughs Wellcome's Actified and Schering-Plough's
Drixoral, with keeping the category lively.
In the cough/cold arena sales shot up 10.9% last year as such former prescription products as Schering-Plough HealthCare Products Inc.'s
Drixoral and Sandoz Inc.'s Tavist-D helped drive business.
Dozens of nonprescription cold products, including items under the Sudafed,
Drixoral, Actifed and Chlor-Trimeton brands, as well as many private label products, would be affected by the DEA proposal, which would require store-level personnel to record every sale.
Robins 4.3% Tavist-D Sandoz 3.7% Alka-Seltzer Plus Miles 3.5% Tylenol multisymptom McNeil 2.7% Triaminic liquid Sandoz 2.7% Vicks Formula 44 Procter & Gamble 2.6% Contac SmithKline Beecham 2.6%
Drixoral Schering 2.4% DayQuil Procter & Gamble 2.2% Theraflu Sandoz 2.1% Actifed Warner-Wellcome 1.9% Tylenol maximum sinus McNeil 1.8% Comtrex Bristol-Myers 1.7% Chlor-Trimeton Schering 1.7% Efidac/24 Ciba 1.4% Tylenol allergy sinus McNeil 1.4% * In dollars, Market share is based on product movement from distribution centers among Towne-Oller reporting retailers for the 12 months through June 1994.
